Another Early Win for TAVI in Low-Risk Patients

Transcatheter aortic-valve implantation (TAVI) has become the dominant, if not default, therapy for patients with severe, symptomatic aortic stenosis who are at intermediate, high, or prohibitive risk for surgical aortic-valve replacement (SAVR). Several randomized trials have shown that TAVI in pat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine 2024-05, Vol.390 (17), p.1623-1625
1. Verfasser:	Shah, Pinak B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aortic stenosis Aortic Valve - surgery Aortic Valve Stenosis - surgery Cardiology Cardiology General Cardiovascular Surgery Clinical trials Heart Humans Patients Risk Risk groups Surgery Transcatheter Aortic Valve Replacement - adverse effects Valvular Heart Disease
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!